Clinical Trial

E-Cigarette Effects on Heart and Lung Disease

Study Description

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease

This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 4 groups: exclusive e-cigarette users, exclusive cigarette smokers, e-cigarette and cigarette users, and a control group of never-users. Participants can expect up to 4 weeks of study participation.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - Cigarettes

smokes daily

Behavioral - E-Cigarettes

E-cigarette usage >/= 5 days/week

Additional Information

Official Study Title

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease Risk (Aka CLUES - Cardiac and LUng E-cig Smoking Study)

Clinical Trial ID

NCT03863509

ParticipAid ID

e0RMVb